Alumis Inc. (ALMS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Alumis Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$7.13
+7.38% today
Market cap
$859M
Overall quality
29/100
Kronos AI 30-day
+121.4%
7 of 8 simulated paths end higher
Alumis Inc. (ALMS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $859M. It trades at $7.13, up 7.38% today. Its overall quality score is 29 out of 100, ranked against the whole US market. 8 analysts' average target of $29.50 implies +313.7% from today's price. Kronos AI's 30-day forecast is +121.4% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $29.50 |
| Low – high | $15.00 – $44.00 |
| Analysts | 8 |
| Upside to average | +313.7% |
Kronos AI 30-day forecast
| Expected close | $14.70 (+121.4%) |
| Likely range | +17.9% … +202.6% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
| Profitability | 5 |
| Solvency | 56 |
| Growth | 27 |
| Overall | 29 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.